Navigation Links
Chemistry turns killer gas into potential cure
Date:10/15/2007

Despite its deadly reputation, the gas carbon monoxide (CO) could actually save lives and boost health in future as a result of leading-edge UK research.

Chemists at the University of Sheffield have discovered an innovative way of using targeted small doses of CO which could benefit patients who have undergone heart surgery or organ transplants and people suffering from high blood pressure.

Although the gas is lethal in large doses, small amounts can reduce inflammation, widen blood vessels, increase blood flow, prevent unwanted blood clotting and even suppress the activity of cells and macrophages* which attack transplanted organs. The researchers have developed innovative water-soluble molecules which, when swallowed or injected, safely release small amounts of CO inside the human body.

Research carried out in the last decade had already highlighted possible advantages, as CO is produced in the body as part of its own natural defensive systems. However, the problem has been finding a safe way of delivering the right dose of CO to the patient. Conventional CO inhalation can run the risk of patients or medical staff being accidentally exposed to high doses. Now for the first time, thanks to chemistry, an answer appears to have been found.

The new CO-releasing molecules (CO-RMs) have been developed in partnership with Dr Roberto Motterlini at Northwick Park Institute for Medical Research (NPIMR) and with funding from the Engineering and Physical Sciences Research Council (EPSRC).

The molecules dissolve in water, so they can be made available in an easy-to-ingest, liquid form that quickly passes into the bloodstream, says Professor Brian Mann, from the University's Department of Chemistry, who led the research. As well as making it simple to control how much CO is introduced into a patients body, it will be possible to refine the design of the molecules so that they target a particular place while leaving the re
'/>"/>

Contact: Natasha Richardson
natasha.richardson@epsrc.ac.uk
44-017-934-44404
Engineering and Physical Sciences Research Council
Source:Eurekalert

Page: 1 2

Related biology news :

1. ASU researchers finds novel chemistry at work to provide parrots vibrant red colors
2. Breakthrough in micro-device fabrication combines biology and synthetic chemistry
3. Male elephants woo females with precise chemistry
4. Computer-chemistry yields new insight into a puzzle of cell division
5. Precision biochemistry tracks DNA damage in fish
6. Smoking changes brain chemistry
7. Comments, experts and background on the 2006 Nobel Prize in chemistry
8. New brain-chemistry differences found in depressed women
9. Lack of enzyme turns fat cells into fat burners
10. Programmable cells: Engineer turns bacteria into living computers
11. Gene therapy turns off mutation linked to Parkinsons disease

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...due University have discovered a new approach for ...ries using nano-spheres that could be injected int...thetic "copolymer micelles" are drug-delivery sphe...0 times smaller than the diameter of a red blood c...iver drugs for cancer treatment and other therapie...
(Date:11/8/2009)...H INTELLECTUAL DISABILITIES: AN OPPORTUNITY FOR HE...olving adults with intellectual disabilities found...nowledge after taking a semi-weekly class for four...cepted term for mental retardation, have slightly ...reventable chronic diseases compared to the genera...
(Date:11/6/2009)...h of the publication of On the Origin of Species, ...S) is publishing open access two peer-reviewed art...ts into evolution. , The two articles are by Kevi..., and James T. Costa of Western Carolina Universit...in," appeared in the October issue of the AIBS jou...
Breaking Biology News(10 mins):Findings show nanomedicine promising for treating spinal cord injuries 2Findings show nanomedicine promising for treating spinal cord injuries 3Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 2Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 3Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 1Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 2Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 3Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 4Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 5Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 6Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 7Antibiotic Resistance Still a Major Public Health Threat 60427 1Antibiotic Resistance Still a Major Public Health Threat 60427 2Antibiotic Resistance Still a Major Public Health Threat 60427 3Antibiotic Resistance Still a Major Public Health Threat 60427 4Asians Seem to Suffer Less During Childbirth 60423 1Asians Seem to Suffer Less During Childbirth 60423 2
... in humans, scientists have found early indicators...-related injuries caused by repetitive motion. , ...on and prevention of debilitating conditions such ... new study from Temple University senior researche...ent, Stephen Carp, in the March issue of Clinical ...
... the Ludwig Institute for Cancer Research (LICR) a...School of Medicine have made a breakthrough in ide...according to a report published online today in Na...ify genes (the ,what,) within the genome, it canno...,when, and ,where, gene products are expressed. Ho...
...was thought to be caused by hypoglycemic coma actu...the coma, according to a study in rodents led by r... , The results are surprising, say the authors, a...nt of diabetics in hypoglycemic coma, though they ...rapolated to humans. , Insulin is an essential ...
Other Biology News:Red flag for repetitive stress injuries identified for first time in humans 2Beyond the DNA: Chemical signatures reveal genetic switches in the genome 2Glucose triggers brain cell death in rats after hypoglycemic coma 2Glucose triggers brain cell death in rats after hypoglycemic coma 3
(Date:11/6/2009)...whead’s 2010 Personalized Medicine Partnersh...uary 22-24, 2010 in Philadelphia, has been announc... key issues in forming partnerships and engage the... Minneapolis, MN (PRWEB) Novemb...10 Personalized Medicine Partnerships Conference ,...
(Date:11/5/2009)...-- The endangered black-footed ferrets inhabit pra...ivore feeds on prairie dogs. The prairie dogs ar...lation die-offs in towns occur. The U.S. Fish &am... breeding program and has been releasing trained, .... Unfortunately, plague can sweep through and dec...
(Date:11/5/2009)...ire-FirstCall/ -- ThermoGenesis Corp. (Nasdaq: KO...r processing and storing adult stem cells, today r...10. ,, For the quarter ended September 30, 2009... 15 percent increase over revenues of $4.5 million... the key contributors to the growth in revenues in...
(Date:11/5/2009)...tCall/ -- BioSpecifics Technologies Corp. (Nasdaq:...irst-in-class collagenase-based products, today an...r ended September 30, 2009. ,, "We were extrem...,s Arthritis Advisory Committee unanimously recomm...TM) for the treatment of Dupuytren,s disease, and ...
Breaking Biology Technology:Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5
...12 New Delhi based Mayuka Labs,Private Limited ha...amp;,development facility from the department of s... ministry of science and technology, Government of...ound the clock at its R&D and Pilot,unit at Na...its first year of,operations. The company has file...
...w white papers detailing sterility testing essenti...test ( www.microtestlabs.com ). The white papers,...cturers and one which is specialized for pharmaceu... and problems associated with sterility testing an...r medical device manufacturers, sterility testing ...
...ista Therapeutics, Inc. (NYSE Alternext US : SY...dy, a Phase 2 double-blind, placebo-controlled, ra...m. The study is designed to measure the effect of ...chronic systolic heart failure. In addition, the C...EAK ( B eginning a R andomized E valuation of th...
Other Biology Technology:Mayuka Labs R&D Centre Gets DSIR Recognition 2Free White Papers Detail Sterility Testing Essentials for Medical Device, Pharmaceutical Manufacturers 2Synvista Therapeutics Announces Progress in Phase 2 Clinical Trial Program for Alagebrium 2Synvista Therapeutics Announces Progress in Phase 2 Clinical Trial Program for Alagebrium 3Synvista Therapeutics Announces Progress in Phase 2 Clinical Trial Program for Alagebrium 4
...gands\n\nReceptor-related research has long been e...abeled ligands selected to keep pace with new disc...ts and services for receptor research and drug dis...igands. If you do not find exactly what you need, ...
...ve and specific detection of microRNAs (miRNAs) by...ave high binding affinity and discrimination, enab...s. Due to the high binding affinity of the miRCURY... needed compared to traditional probes. Furthermor...
Rabbit Anti-Mouse Vitronectin Polyclonal Antibody, Unconjugated from Abcam
...methylation is an irreversible post translational ...o protein activity. At least three types of PRMT e...ese enzymes have been shown to have essential regu... several fundamental areas. These protein include ...
Biology Products: